Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type

被引:60
作者
Perco, P
Shao, CP
Mayr, WR
Panzer, S
Legler, TJ
机构
[1] Univ Gottingen, Dept Transfus Med, D-37075 Gottingen, Germany
[2] Univ Vienna, Clin Dept Blood Grp Serol, A-1010 Vienna, Austria
关键词
D O I
10.1046/j.1537-2995.2003.00313.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The discrimination of D+/D+ from D+/D- partners of D- mothers with anti-D is important to estimate the risk for HDN. This may be achieved if the presence or absence of the hybrid Rhesus box in the father can be demonstrated. STUDY DESIGN AND METHODS: A new PCR-SSP method specific for the hybrid Rhesus box comprising an internal amplification control was compared with two published PCR-based methods (PCR-SSP and PCR-RFLP) in 83 D+, 13 D-, and 37 weak D samples. RESULTS: The deletion of RHD was detectable in all D- and weak D samples. By all three methods, concordant results were obtained in 82 of 83 D+ samples, with one sample showing discrepant results. The control band in the PCR-RFLP method, specific for the downstream Rhesus box, was missing in two weak D samples, namely a weak D type 4.0 and a novel weak D type dubbed weak D type 29. Further investigations revealed an altered downstream Rhesus box in the weak D type 29 sample. In the weak D type 4.0 sample, no amplicon was achieved with any primer specific for the upstream and downstream Rhesus box. CONCLUSION: A PCR-SSP method with internal control was established for the detection of the hybrid Rhesus box. Polymorphisms in the downstream Rhesus box may interfere with the detection of RHD.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 14 条
[1]  
Chiu RWK, 2001, CLIN CHEM, V47, P667
[2]  
COLIN Y, 1991, BLOOD, V78, P2747
[3]   Rh D/d genotyping by quantitative polymerase chain reaction and capillary zone electrophoresis [J].
Cossu, G ;
Angius, A ;
Gelfi, C ;
Righetti, PG .
ELECTROPHORESIS, 1996, 17 (12) :1911-1915
[4]   Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients [J].
Legler, TJ ;
Eber, SW ;
Lakomek, M ;
Lynen, R ;
Maas, JH ;
Pekrun, A ;
Repas-Humpe, M ;
Schröter, W ;
Köhler, M .
TRANSFUSION, 1999, 39 (08) :852-855
[5]   RHD genotyping in weak D phenotypes by multiple polymerase chain reactions [J].
Legler, TJ ;
Maas, JH ;
Blaschke, V ;
Malekan, M ;
Ohto, H ;
Lynen, R ;
Bustami, N ;
Schwartz, DWM ;
Mayr, WR ;
Köhler, M ;
Panzer, S .
TRANSFUSION, 1998, 38 (05) :434-440
[6]   RHD sequencing:: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis [J].
Legler, TJ ;
Maas, JH ;
Köhler, M ;
Wagner, T ;
Daniels, GL ;
Perco, P ;
Panzer, S .
TRANSFUSION MEDICINE, 2001, 11 (05) :383-388
[7]   Novel 3′ Rhesus box sequences confound RHD zygosity assignment [J].
Matheson, KA ;
Denomme, GA .
TRANSFUSION, 2002, 42 (05) :645-650
[8]   RhD genotype determination by single sperm cell analysis [J].
Reubinoff, BE ;
Avner, R ;
Rojansky, N ;
Manny, N ;
Friedmann, A ;
Laufer, N ;
MitraniRosenbaum, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (04) :1300-1305
[9]   Molecular background of Rh D-positive, D-negative, Del and weak D phenotypes in Chinese [J].
Shao, CP ;
Maas, JH ;
Su, YQ ;
Köhler, M ;
Legler, TJ .
VOX SANGUINIS, 2002, 83 (02) :156-161
[10]  
Singleton BK, 2000, BLOOD, V95, P12